Browsing: CAR-T

Groundbreaking CD7 CAR-T therapy from NUS Medicine offers hope for T-cell acute lymphoblastic leukaemia (T-ALL) patients. Early case reports show 16 of 17 achieved remission, marking a significant cancer treatment advancement for relapsed/refractory T-ALL.

Three T-ALL patients – Viet Tai, Maria, and Hannah – share their inspiring cancer journeys through an innovative CD7 CAR-T therapy treatment, pioneered by researchers and clinicians from the NUS Medicine and NUHS and cultivated in-house by a modest laboratory in Singapore.

Log In or Register as a healthcare professional to read the full article.

This accolade, which celebrates their dedication and significant contributions to the research community in Singapore, was presented by the Singapore Clinical Research Institute (SCRI). Now in its fourth year since its inauguration in 2019, the award saw 34 commendable nominations from public healthcare institutions. Among the recipients, Geraldine Lim was awarded the distinction award, and three others were awarded the merit award. The other recipients received finalist awards.

台湾女童亭亭在6岁时被诊断出罹患儿童B细胞急性淋巴性白血病，经各種傳統治療癌症任然复发。通过CAR-T細胞治療，如今体内的癌细胞已完全根除！